Cost-effectiveness evaluation of quadrivalent influenza vaccines for seasonal influenza prevention: a dynamic modeling study of Canada and the United Kingdom

BACKGROUND: The adoption of quadrivalent influenza vaccine (QIV) to replace trivalent influenza vaccine (TIV) in immunization programs is growing worldwide, thus helping to address the problem of influenza B lineage mismatch. However, the price per dose of QIV is higher than that of TIV. In such cir...

Descripción completa

Detalles Bibliográficos
Autores principales: Thommes, Edward W., Ismaila, Afisi, Chit, Ayman, Meier, Genevieve, Bauch, Christopher T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4623926/
https://www.ncbi.nlm.nih.gov/pubmed/26503131
http://dx.doi.org/10.1186/s12879-015-1193-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4623926/
https://www.ncbi.nlm.nih.gov/pubmed/26503131
http://dx.doi.org/10.1186/s12879-015-1193-4

Ejemplares similares